Abstract

BackgroundMethylenetetrahydrofolate reductase (MTHFR), a critical enzyme in folate metabolism is involved in DNA synthesis, DNA repair and DNA methylation. The functional polymorphism of MTHFR gene, C677T has been shown to impact various diseases and implicated as a risk factor for the development of various neurodegenerative disorders including glaucoma.MethodsWe investigated MTHFR C677T genotypes and alleles frequencies in primary glaucoma [primary open angle glaucoma (POAG) and primary angle closure glaucoma (PACG)] patients and matched healthy controls in a case-control study. Two hundred ten primary glaucoma cases were studied for MTHFR C677T polymorphism and compared with 280 controls taken from the healthy population, employing the polymerase chain reaction-restriction fragment length polymorphism technique (PCR-RFLP). The MTHFR gene was amplified using specific primers. The PCR products (294 bp) was subsequently digested with HinfI (New England Biolabs) at 37 °C for 12 h, separated by electrophoresis on 2 % agarose gels, and visualized with ethidium bromide staining. The restriction digestion yielded 168 and 126 bp fragments for TT, 294, 168 and 126 bp fragments for CT and undigested PCR product 294 bp indicating CC genotype.ResultsWe found the frequency of the genotypes and alleles of MTHFR C677T differ significantly between cases and controls. The frequencies of allele T and genotype CT were significantly higher while the frequencies of allele C and genotype CC were lower in primary glaucoma patients as compared to controls (p <0.05). Upon stratification of our results into POAG and PACG, significantly higher frequencies of allele T (19.44 %) and genotype CT (38.89 %) were found in POAG patients compared to controls (12.5 % and 25 % respectively). The frequencies of alleles and genotypes were almost similar in PACG and controls (p = 0.8).ConclusionThis study indicates that the allele T and genotype CT of MTHFR C677T polymorphism are significantly associated with POAG while allele C and CC genotype may be protective for it. We conclude that the MTHFR C677T polymorphism increases the risk for POAG development in Saudi population and can be a genetic marker however, further studies are needed with multiple-ethnic populations affected with POAG to strengthen these findings.

Highlights

  • Methylenetetrahydrofolate reductase (MTHFR), a critical enzyme in folate metabolism is involved in DNA synthesis, DNA repair and DNA methylation

  • The results of the genotypes and alleles distribution of MTHFR C677T polymorphism in Primary glaucoma (PG) and controls are summarized in Tables 2, 3, 4, 5

  • The higher frequency of CT genotype and allele T in primary open angle glaucoma (POAG) indicated that the genotype CT and allele T of MTHFR C677T polymorphism might be associated with susceptibility risk of POAG (RR = 1.91, etiologic fraction (EF) = 0.211) while the decreased frequency of genotype CC in POAG as compared to controls indicated that genotype CC may be resistant to POAG in Saudis

Read more

Summary

Introduction

Methylenetetrahydrofolate reductase (MTHFR), a critical enzyme in folate metabolism is involved in DNA synthesis, DNA repair and DNA methylation. Glaucoma is the second leading cause of blindness worldwide It is a relatively common eye disease characterized by the pathological loss of retinal ganglion cells resulting into progressive loss of sight and related changes in the retinal nerve fiber layer and optic nerve head [1]. MTHFR C677T polymorphism leads to an increase in thermolability and reduced activity of the MTHFR enzyme [12] This reduction in enzymatic activity of MTHFR leads to the elevation of homocysteine levels in plasma [13]. MTHFR (EC1.5.1.20), being a crucial enzyme in the pathway, diverts folate content towards homocysteine remethylation This enzyme catalyzes reduction of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, which acts as methyl donor for remethylation of homocysteine to methionine [13]

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call